Chargement en cours...
Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis
Clinical evidence demonstrates coadministration of tumour necrosis factor inhibitor (TNFi) agents and methotrexate (MTX) is more efficacious than administration of TNFi agents alone in patients with rheumatoid arthritis, leading to the perception that coadministration of MTX with all biologic agents...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3841743/ https://ncbi.nlm.nih.gov/pubmed/23918035 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2013-203485 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|